Azevan Pharmaceuticals
PrivateLast Round
Grant
Mar 1, 2026
Total Funding Raised
$11.6M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Azevan Pharmaceuticals operates in Healthcare & Life Sciences and is based in Bethlehem, Pennsylvania. Its latest recorded funding round was a Series C round in October 2013.
Azevan Pharmaceuticals is a biotechnology company that develops novel small-molecule therapeutics to treat stress-related central nervous system disorders and neurodegenerative conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Mental Health
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Azevan Pharmaceuticals Comparables
Compare Azevan Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neuphoria Therapeutics Inc. | 77% | |
| MapLight Therapeutics | 73% | |
| Nobilis Therapeutics | 73% |
For institutional investors. Book with your work email.
Azevan Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 1, 2026 | ||||
| Series C | Oct 1, 2013 |
For institutional investors. Book with your work email.
Azevan Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| United States Department of Defense | Grant |
| Scientific Health Development | Series C |
| National Institute of Neurological Disorders and Stroke (NINDS) | Grant |
| Ascent Biomedical Ventures | Series C |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Received grant from the United States Department of Defense.
- Jan 31, 2026
Monthly visitors grew 92% MoM.
For institutional investors. Book with your work email.
Azevan Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Azevan Pharmaceuticals's valuation, stock price, and market status.
Is Azevan Pharmaceuticals a public or private company?
Azevan Pharmaceuticals is a private company.
What is the current stock price of Azevan Pharmaceuticals?
Azevan Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Azevan Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Azevan Pharmaceuticals worth (valuation)?
Valuation information for Azevan Pharmaceuticals is not publicly available.
Can I buy Azevan Pharmaceuticals stock?
Azevan Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Azevan Pharmaceuticals's last funding round?
Azevan Pharmaceuticals's most recent funding round was Grant on March 1, 2026.
Who are the main investors in Azevan Pharmaceuticals?
Key investors in Azevan Pharmaceuticals include United States Department of Defense, Scientific Health Development, National Institutes of Health (NIH).
Will Azevan Pharmaceuticals IPO soon?
No public IPO plans have been announced for Azevan Pharmaceuticals.
How can I track Azevan Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Azevan Pharmaceuticals's shares on secondary markets.